370 related articles for article (PubMed ID: 33916879)
41. Circulating 4-F
Signorini C; Leoncini S; Durand T; Galano JM; Guy A; Bultel-Poncé V; Oger C; Lee JC; Ciccoli L; Hayek J; De Felice C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921863
[TBL] [Abstract][Full Text] [Related]
42. Regulation, diversity and function of MECP2 exon and 3'UTR isoforms.
Rodrigues DC; Mufteev M; Ellis J
Hum Mol Genet; 2020 Sep; 29(R1):R89-R99. PubMed ID: 32681172
[TBL] [Abstract][Full Text] [Related]
43. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
44. Treating Rett syndrome: from mouse models to human therapies.
Vashi N; Justice MJ
Mamm Genome; 2019 Jun; 30(5-6):90-110. PubMed ID: 30820643
[TBL] [Abstract][Full Text] [Related]
45. WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome.
Haase F; Gloss BS; Tam PPL; Gold WA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576118
[TBL] [Abstract][Full Text] [Related]
46. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action.
Bedogni F; Rossi RL; Galli F; Cobolli Gigli C; Gandaglia A; Kilstrup-Nielsen C; Landsberger N
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():187-201. PubMed ID: 24594195
[TBL] [Abstract][Full Text] [Related]
47. Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.
Leoncini S; De Felice C; Signorini C; Zollo G; Cortelazzo A; Durand T; Galano JM; Guerranti R; Rossi M; Ciccoli L; Hayek J
Oxid Med Cell Longev; 2015; 2015():421624. PubMed ID: 26236424
[TBL] [Abstract][Full Text] [Related]
48. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells.
Cheung AY; Horvath LM; Carrel L; Ellis J
Front Psychiatry; 2012; 3():24. PubMed ID: 22470355
[TBL] [Abstract][Full Text] [Related]
49. Generation of human induced pluripotent stem cell lines derived from four Rett syndrome patients with MECP2 mutations.
Mori M; Yoshii S; Noguchi M; Takagi D; Shimizu T; Ito H; Matsuo-Takasaki M; Nakamura Y; Takahashi S; Hamada H; Ohnuma K; Shiohama T; Hayashi Y
Stem Cell Res; 2024 Jun; 77():103432. PubMed ID: 38703668
[TBL] [Abstract][Full Text] [Related]
50. Wide spectrum of neuronal and network phenotypes in human stem cell-derived excitatory neurons with Rett syndrome-associated MECP2 mutations.
Mok RSF; Zhang W; Sheikh TI; Pradeepan K; Fernandes IR; DeJong LC; Benigno G; Hildebrandt MR; Mufteev M; Rodrigues DC; Wei W; Piekna A; Liu J; Muotri AR; Vincent JB; Muller L; Martinez-Trujillo J; Salter MW; Ellis J
Transl Psychiatry; 2022 Oct; 12(1):450. PubMed ID: 36253345
[TBL] [Abstract][Full Text] [Related]
51.
Anitha A; Poovathinal SA; Viswambharan V; Thanseem I; Iype M; Anoop U; Sumitha PS; Parakkal R; Vasu MM
Neurol India; 2022; 70(1):249-253. PubMed ID: 35263890
[TBL] [Abstract][Full Text] [Related]
52. A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain.
Carli S; Chaabane L; De Rocco G; Albizzati E; Sormonta I; Calligaro S; Bonizzi P; Frasca A; Landsberger N
Neurobiol Dis; 2023 May; 180():106083. PubMed ID: 36931532
[TBL] [Abstract][Full Text] [Related]
53. MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells.
Djuric U; Cheung AYL; Zhang W; Mok RS; Lai W; Piekna A; Hendry JA; Ross PJ; Pasceri P; Kim DS; Salter MW; Ellis J
Neurobiol Dis; 2015 Apr; 76():37-45. PubMed ID: 25644311
[TBL] [Abstract][Full Text] [Related]
54. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
55. Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method.
Huber A; Sarne V; Beribisky AV; Ackerbauer D; Derdak S; Madritsch S; Etzler J; Huck S; Scholze P; Gorgulu I; Christodoulou J; Studenik CR; Neuhaus W; Connor B; Laccone F; Steinkellner H
Stem Cells Dev; 2024 Mar; 33(5-6):128-142. PubMed ID: 38164119
[TBL] [Abstract][Full Text] [Related]
56. Multiplex epigenome editing of
Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
[TBL] [Abstract][Full Text] [Related]
57. Surface- and voxel-based brain morphologic study in Rett and Rett-like syndrome with MECP2 mutation.
Shiohama T; Levman J; Takahashi E
Int J Dev Neurosci; 2019 Apr; 73():83-88. PubMed ID: 30690146
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic Potential of Transcranial Focused Ultrasound for Rett Syndrome.
Tsai SJ
Med Sci Monit; 2016 Oct; 22():4026-4029. PubMed ID: 27786169
[TBL] [Abstract][Full Text] [Related]
59. MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling.
Nakashima H; Tsujimura K; Irie K; Imamura T; Trujillo CA; Ishizu M; Uesaka M; Pan M; Noguchi H; Okada K; Aoyagi K; Andoh-Noda T; Okano H; Muotri AR; Nakashima K
Cell Rep; 2021 May; 35(7):109124. PubMed ID: 34010654
[TBL] [Abstract][Full Text] [Related]
60. Mutational analysis of methyl-CpG binding protein 2 (MECP2) gene in Indian cases of Rett syndrome.
Das DK; Udani V; Sanghavi D; Adhia R; Maitra A
J Clin Lab Anal; 2013 Mar; 27(2):137-42. PubMed ID: 23400946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
